Amedisys Inc (NASDAQ:AMED) — Market Cap & Net Worth
Market Cap & Net Worth: Amedisys Inc (AMED)
Amedisys Inc (NASDAQ:AMED) has a market capitalization of $3.32 Billion ($3.32 Billion) as of September 16, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #4615 globally and #1575 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Amedisys Inc's stock price $100.99 by its total outstanding shares 32887700 (32.89 Million). Also see Amedisys Inc total assets for a full breakdown of the balance sheet.
Amedisys Inc Market Cap History: 2015 to 2025
Amedisys Inc's market capitalization history from 2015 to 2025. Data shows growth from $1.29 Billion to $3.32 Billion (9.63% CAGR). Also see cash flow conversion of Amedisys Inc for how efficiently the company converts equity into cash flow.
Index Memberships
Amedisys Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.66 Trillion | 0.12% | #120 of 976 |
|
NASDAQ Composite
IXIC
|
$41.74 Trillion | 0.01% | #528 of 3165 |
|
S&P Midcap 400
MID
|
$3.41 Trillion | 0.12% | #344 of 401 |
Weight: Amedisys Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Amedisys Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Amedisys Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Amedisys Inc for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1.27x
Amedisys Inc's market cap is 1.27 times its annual revenue
Latest Price to Earnings (P/E) Ratio
69.07x
Amedisys Inc's market cap is 69.07 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.29 Billion | $1.28 Billion | -$3.02 Million | 1.01x | N/A |
| 2016 | $1.40 Billion | $1.44 Billion | $37.26 Million | 0.98x | 37.63x |
| 2017 | $1.73 Billion | $1.53 Billion | $30.30 Million | 1.13x | 57.21x |
| 2018 | $3.85 Billion | $1.66 Billion | $119.35 Million | 2.32x | 32.27x |
| 2019 | $5.49 Billion | $1.96 Billion | $126.83 Million | 2.81x | 43.28x |
| 2020 | $9.65 Billion | $2.07 Billion | $183.61 Million | 4.66x | 52.54x |
| 2021 | $5.32 Billion | $2.21 Billion | $209.07 Million | 2.40x | 25.46x |
| 2022 | $2.75 Billion | $2.22 Billion | $118.61 Million | 1.24x | 23.16x |
| 2023 | $3.13 Billion | $2.24 Billion | -$9.75 Million | 1.40x | N/A |
| 2024 | $2.99 Billion | $2.35 Billion | $43.23 Million | 1.27x | 69.07x |
Competitor Companies of AMED by Market Capitalization
Companies near Amedisys Inc in the global market cap rankings as of September 16, 2026. Review AMED goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Amedisys Inc by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #288 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #911 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #1001 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1234 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #288 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $423.82 |
| #911 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €45.39 |
| #1001 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1234 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $260.85 |
Amedisys Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Amedisys Inc's market cap moved from $1.29 Billion to $ 3.32 Billion, with a yearly change of 9.63%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $3.32 Billion | +11.23% |
| 2024 | $2.99 Billion | -4.49% |
| 2023 | $3.13 Billion | +13.79% |
| 2022 | $2.75 Billion | -48.39% |
| 2021 | $5.32 Billion | -44.81% |
| 2020 | $9.65 Billion | +75.73% |
| 2019 | $5.49 Billion | +42.53% |
| 2018 | $3.85 Billion | +122.18% |
| 2017 | $1.73 Billion | +23.65% |
| 2016 | $1.40 Billion | +8.42% |
| 2015 | $1.29 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 13th, 2026 the market cap of Amedisys Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.32 Billion USD |
| MoneyControl | $3.32 Billion USD |
| MarketWatch | $3.32 Billion USD |
| marketcap.company | $3.32 Billion USD |
| Reuters | $3.32 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Amedisys Inc
Amedisys, Inc. provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment provides a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services,… Read more